Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Complicaciones relacionadas con la EXtubación: el estudio EXTUBE (EXTUBE) (EXTUBE)

19 de octubre de 2026 actualizado por: University Health Network, Toronto

Complicaciones relacionadas con la EXtubación: un estudio observacional internacional para comprender el impacto y las mejores prácticas en el quirófano y la unidad de cuidados intensivos: el estudio EXTUBE

EXTUBE is an international, multicentre, prospective cohort study evaluating the incidence, risk factors, and outcomes of extubation-related complications and describing clinical practices related to extubation after general anesthesia or after critical illness in the operating room (OR), out of OR anesthesia location or intensive care unit (ICU).

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Descripción detallada

Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.

Despite the frequency of extubation and the potential for life-threatening complications, there is a lack of systematic data on the rate and circumstances under which these severe complications occur. The limited data indicate 10-30% of extubations may lead to severe complications, depending on the population and outcome definition. However, the certainty of these estimates is severely limited because they are based on studies that are small, mostly single-center, based on clinician recall, only capture a small portion of extubation complications (e.g., malpractice claims), or do not reflect current clinical practice. In addition, most lack a denominator and exclude successful extubations, making estimates of actual complication rates and risk factors impossible.

There has been no large study of extubation techniques or adherence to guidelines, so procedural factors associated with complications must be elucidated. While adherence to clinical practice guidelines has not been formally evaluated, surveys show non-adherence to some best practices and considerable variation in practice, and data from audits and medicolegal claims show that lack of adherence to best practices is frequently at the root cause of severe adverse extubation outcomes, with half of the complications deemed preventable. Therefore, data on the frequency and nature of extubation complications, patient and procedural risk factors for complications, and guideline adherence rates are needed before these preventable events can be addressed.

EXTUBE (EXtubation related complications - an international observational study To Understand the impact and BEst practices in the operating room and intensive care unit) is an international, multicenter, prospective cohort study

The primary objective of this study is to estimate the incidence of immediate complications related to extubation in adult patients after general anesthesia and/or after critical illness. The secondary objectives are to determine: 1) the incidence of mild extubation complications; 2) patient- and procedure-related risk factors for extubation complications; 3) the association between extubation complications and outcomes until hospital discharge; and 4) the rate of adherence to extubation clinical practice guidelines.

Tipo de estudio

De observación

Inscripción (Estimado)

3000

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Matteo Parotto, MD, PhD
  • Número de teléfono: +1 416 340 3567
  • Correo electrónico: matteo.parotto@uhn.ca

Copia de seguridad de contactos de estudio

  • Nombre: Shayan Wasim, MPH, BSc
  • Número de teléfono: 4221 +1 416 340 4800
  • Correo electrónico: shayan.wasim@uhn.ca

Ubicaciones de estudio

    • New South Wales
      • Sydney, New South Wales, Australia, 2065
        • Terminado
        • Royal North Shore Hospital
    • Victoria
      • Melbourne, Victoria, Australia, 3135
        • Terminado
        • Eastern Health - Maroondah Hospital
      • Melbourne, Victoria, Australia, 3156
        • Terminado
        • Eastern Health - Angliss Hospital
      • Melbourne, Victoria, Australia, 3076
        • Terminado
        • The Northern Hospital
      • Melbourne, Victoria, Australia, 3128
        • Terminado
        • Eastern Health - Box Hill Hospital
      • Melbourne, Victoria, Australia, 3084
        • Terminado
        • Austin Health - Austin Hospital
      • Melbourne, Victoria, Australia, 3079
        • Terminado
        • Austin Health - Heidelberg Repatriation Hospital
    • British Columbia
      • Surrey, British Columbia, Canadá, V3V 1Z2
        • Terminado
        • Surrey Memorial Hospital
    • New Brunswick
      • Moncton, New Brunswick, Canadá, E1C 4B7
        • Terminado
        • The Moncton Hospital
    • Ontario
      • North York, Ontario, Canadá, M4N 3M5
        • Terminado
        • Sunnybrook Hospital
      • Saint Catharines, Ontario, Canadá, L2S 0A9
        • Terminado
        • Niagara Health - Marotta Family Hospital
      • Toronto, Ontario, Canadá, M5B 1W8
        • Terminado
        • St. Michael's Hospital
      • Toronto, Ontario, Canadá, M5G 1X5
        • Terminado
        • Mount Sinai Hospital
      • Toronto, Ontario, Canadá, M5G 2C4
        • Reclutamiento
        • University Health Network - Toronto General Hospital
        • Contacto:
          • Shayan Wasim, MPH, BSc
          • Número de teléfono: 4221 416-340-4800
          • Correo electrónico: shayan.wasim@uhn.ca
        • Investigador principal:
          • Matteo Parotto, MD, PhD
        • Contacto:
        • Sub-Investigador:
          • Alicia Grassi, MD
      • Toronto, Ontario, Canadá, M5T 2S8
        • Terminado
        • University Health Network - Toronto Western Hospital
    • Quebec
      • Montreal, Quebec, Canadá, H2X 0C1
        • Terminado
        • Centre hospitalier de l'Université de Montréal (CHUM)
      • Piedecuesta, Colombia
        • Terminado
        • Hospital Internacional de Colombia
    • Arizona
      • Tucson, Arizona, Estados Unidos, 85724-5114
        • Terminado
        • Banner University Medical Centre
    • Arkansas
      • Little Rock, Arkansas, Estados Unidos, 72205
        • Terminado
        • University of Arkansas for Medical Sciences
    • Florida
      • Gainesville, Florida, Estados Unidos, 32608
        • Terminado
        • University of Florida
    • Illinois
      • Chicago, Illinois, Estados Unidos, 60637
        • Terminado
        • The University of Chicago
    • Oregon
      • Portland, Oregon, Estados Unidos, 97239
        • Terminado
        • Oregon Health & Science University
    • Texas
      • Houston, Texas, Estados Unidos, 77030
        • Terminado
        • The University of Texas Health Science Center
      • Castlebar, Irlanda, F23 H529
        • Terminado
        • Mayo University Hospital
      • Cork, Irlanda, T12 DFK4
        • Terminado
        • Cork University Hospital
      • Dublin, Irlanda, D07 R2WY
        • Terminado
        • Mater Misericordiae University Hospital
      • Galway, Irlanda, H91 YR71
        • Terminado
        • Galway University Hospitals
      • Waterford, Irlanda, X91 ER8E
        • Aún no reclutando
        • University Hospital Waterford
        • Contacto:
        • Contacto:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
          • Número de teléfono: (+353) 0518482425
          • Correo electrónico: dulmi.nawarathna@hse.ie
        • Investigador principal:
          • Dulmi T Nawarathna, MBBS, MCAI, FCAI
        • Sub-Investigador:
          • Sheeba Hakak, MBBS, FCARCSI, EDIC, HCM.
      • Kuwait City, Kuwait
        • Terminado
        • Amiri Hospital
      • Auckland, Nueva Zelanda, 1023
        • Terminado
        • Auckland City Hospital
      • Invercargill, Nueva Zelanda, 9812
        • Terminado
        • Southland Hospital
      • Rotorua, Nueva Zelanda, 3010
        • Terminado
        • Rotorua Hospital
      • Bath, Reino Unido, BA1 3NG
        • Terminado
        • Royal United Hospitals Bath
      • Newcastle upon Tyne, Reino Unido, NE7 7DN
        • Terminado
        • Freeman Hospital
      • Singapore, Singapur, 308433
        • Terminado
        • Tan Tock Seng Hospital

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra de probabilidad

Población de estudio

All adult patients (≥18 years old) undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU during the specified enrollment window (up to 4 weeks).

Descripción

Inclusion Criteria:

  • Adult patients (≥18 years old)
  • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
  • Undergoing extubation during the specified enrollment window

Exclusion Criteria:

  • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
  • Patients will be excluded if the extubation is performed for tracheostomy decannulation

For each patient who is not included, reasons for exclusion will be reported.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: PROSPECTIVE

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
At least one of the following, occurring within 60minutes after extubation (composite outcome): i) Severe hypoxemia ii) Cardiac arrest iii) Need for airway management
Periodo de tiempo: Within 60 minutes after the end of extubation

The primary outcome will be the occurrence of at least one of the following (composite outcome) occurring within 60 minutes after the end of extubation:

i) Severe hypoxemia (oxygen saturation as measured by pulse oximetry falls below SpO2 < 80% for > 5 minutes) ii) Cardiac arrest iii) Need for airway management (reintubation, insertion of a supraglottic airway, bag-mask ventilation).

Within 60 minutes after the end of extubation

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Difficult airway and complications related to airway management if reintubation is required
Periodo de tiempo: Within 60 minutes after the end of extubation

Difficult airway (i.e., experienced difficulty by an experienced airway manager with any or all of laryngoscopy or tracheal intubation, supraglottic airway use, face-mask ventilation, or front-of-neck airway) and complications related to airway management (e.g., esophageal intubation) if reintubation is required

Within 60 minutes after the end of extubation
Planned and unplanned non-invasive respiratory support
Periodo de tiempo: Within 60 minutes after the end of extubation

Planned and unplanned non-invasive respiratory support or high flow nasal cannula

Within 60 minutes after the end of extubation
Emergency front of neck airway
Periodo de tiempo: Within 60 minutes after the end of extubation

Emergency front of neck airway should airway management be required after extubation

Within 60 minutes after the end of extubation
Cardiac arrhythmia requiring chemical or electrical treatment
Periodo de tiempo: Within 60 minutes after the end of extubation

Cardiac arrhythmia requiring chemical or electrical treatment

Within 60 minutes after the end of extubation
Severe Hypotension
Periodo de tiempo: Within 60 minutes after the end of extubation

Severe hypotension (systolic arterial pressure < 65 mmHg recorded at any time or systolic arterial pressure < 90 mmHg for > 30 minutes or new need/increase of vasopressor and/or fluid load > 15 mL/kg)

Within 60 minutes after the end of extubation
Severe Hypertension
Periodo de tiempo: Within 60 minutes after the end of extubation

Severe hypertension (systolic blood pressure ≥180 mmHg and/or diastolic blood pressure ≥120 mmHg),

Within 60 minutes after the end of extubation
Pulmonary aspiration
Periodo de tiempo: Within 60 minutes after the end of extubation

Aspiration of gastric contents (gastric contents inhaled into the larynx and the respiratory tract)

Within 60 minutes after the end of extubation
Barotrauma
Periodo de tiempo: Within 60 minutes after the end of extubation

Pneumothorax/pneumo-mediastinum

Within 60 minutes after the end of extubation
Dental injury
Periodo de tiempo: Within 60 minutes after the end of extubation

Dental injury (notable change to the patient's dentition attributable to extubation or to reintubation, should this be required)

Within 60 minutes after the end of extubation
Airways injury
Periodo de tiempo: Within 60 minutes after the end of extubation

Airways injury (e.g., vocal cord damage, arytenoid dislocation

Within 60 minutes after the end of extubation
Mortality
Periodo de tiempo: Within 7 days after extubation

In-hospital mortality

Within 7 days after extubation
Re-intubation
Periodo de tiempo: Within 48 hours after extubation

Re-intubation within 48 hours of extubation

Within 48 hours after extubation

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Matteo Parotto, MD, PhD, UHN

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

14 de abril de 2025

Finalización primaria (Estimado)

1 de diciembre de 2027

Finalización del estudio (Estimado)

1 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

28 de marzo de 2024

Primero enviado que cumplió con los criterios de control de calidad

3 de junio de 2024

Publicado por primera vez (Actual)

5 de junio de 2024

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

22 de octubre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

19 de octubre de 2026

Última verificación

1 de agosto de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 24-5811
  • 4850 (Otro identificador: Clinical Trials Ontario - CTO)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir